SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.

Autor: Alghamdi AS; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia., Alghamdi H; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alserehi HA; General Directorate of Communicable Diseases, Ministry of Health, Riyadh, Saudi Arabia., Babatin MA; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia., Alswat KA; Liver Disease Research Center, and Riyadh, Saudi Arabia.; College of Medicine, King Saud University, Riyadh, Saudi Arabia., Alghamdi M; Department of Medicine, Division of Gastroenterology, King Fahd Military Complex, Dhahran, Saudi Arabia., AlQutub A; Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia., Abaalkhail F; Department of Medicine, Section of Gastroenterology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; College of Medicine, Al Faisal University, Riyadh, Saudi Arabia., Altraif I; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia., Alfaleh FZ; Liver Disease Research Center, and Riyadh, Saudi Arabia., Sanai FM; Liver Disease Research Center, and Riyadh, Saudi Arabia.; Gastroenterology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Jazyk: angličtina
Zdroj: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2024 Jan 01; Vol. 30 (Supp 1), pp. S1-S42. Date of Electronic Publication: 2024 Jan 03.
DOI: 10.4103/sjg.sjg_333_23
Abstrakt: Abstract: Hepatitis C virus (HCV) infection has been a major global health concern, with a significant impact on public health. In recent years, there have been remarkable advancements in our understanding of HCV and the development of novel therapeutic agents. The Saudi Society for the Study of Liver Disease and Transplantation formed a working group to develop HCV practice guidelines in Saudi Arabia. The methodology used to create these guidelines involved a comprehensive review of available evidence, local data, and major international practice guidelines regarding HCV management. This updated guideline encompasses critical aspects of HCV care, including screening and diagnosis, assessing the severity of liver disease, and treatment strategies. The aim of this updated guideline is to assist healthcare providers in the management of HCV in Saudi Arabia. It summarizes the latest local studies on HCV epidemiology, significant changes in virus prevalence, and the importance of universal screening, particularly among high-risk populations. Moreover, it discusses the promising potential for HCV elimination as a public health threat by 2030, driven by effective treatment and comprehensive prevention strategies. This guideline also highlights evolving recommendations for advancing disease management, including the treatment of HCV patients with decompensated cirrhosis, treatment of those who have previously failed treatment with the newer medications, management in the context of liver transplantation and hepatocellular carcinoma, and treatment for special populations.
(Copyright © 2023 Copyright: © 2023 Saudi Journal of Gastroenterology.)
Databáze: MEDLINE
Externí odkaz: